2024 CRT Conference

Back

85 Views

Late-Breaking

Late-Breaking Artificial Intelligence Clinical Trials [Non-CME]

Monday, March 11, 2024

8:00 AM – 9:00 AM ET

Moderator(s)

Ori Ben-Yehuda, MD

Professor of Medicine
University of California, San Diego
La Jolla, California, United States
Justin Davies, MD, PhD

Cardiologist
Imperial College London
London, England, United Kingdom
Chaim Lotan, MD

Director Heart Institute
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

Panel Discussant(s)

Federico Asch, MD

Director, Cardiovascular Core Labs and Cardiac Imaging Research
MedStar Health Research Institute
Washington, District of Columbia, United States
Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

Interventional Cardiologist
John Muir Health Cardiovascular Institute
San Francisco, California, United States
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
David Kong, MD, AM, DMT

Associate Professor of Medicine
Duke University
Durham, North Carolina, United States

Disclosure(s):

Ori Ben-Yehuda, MD: Bioventrix, Inc: Consultant (Ongoing); Cardiovalve: Advisor (Ongoing), Consultant (Ongoing)

Justin E. Davies, MD, PhD: No relationships to disclose

Chaim Shaul Lotan, MD: No relationships to disclose

Federico M. Asch, MD: No relationships to disclose

C. Michael Gibson, MD: Absolutys: Shareholder (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); AstraZeneca Pharmaceuticals: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing); Beren Therapeutics: Consultant (Ongoing); Bioclinica: Consultant (Ongoing); BOEHRINGER INGELHEIM IT.SpA.: Consultant (Ongoing); Boston Clinical Research Institute: Consultant (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing); Boston Scientific: Consultant (Ongoing); Bristol Meyers Squibb: Consultant (Ongoing); Cardiovascular Research Foundation: Consultant (Ongoing); CeleCor Therapeutics: Consultant (Ongoing); CSL-Behring: Consultant (Ongoing), Grant/Research Support (Ongoing); Duke Clinical Research Institute: Consultant (Ongoing); Dyad Medical: Shareholder (Ongoing); Esperion: Consultant (Ongoing); EXCITE International: Advisor (Ongoing); Fortress Biotech: Consultant (Ongoing), Consultant (Ongoing), Shareholder (Ongoing), Shareholder (Ongoing); Gilead: Consultant (Ongoing); Inari: Consultant (Ongoing); Janssen Research & Development LLC: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Grant/Research Support (Ongoing); MashUP MD: Consultant (Ongoing); MD Magazine: Consultant (Ongoing); Merck Pharmaceuticals: Consultant (Ongoing); MicroPort Medical: Consultant (Ongoing); MJH Life Sciences: Consultant (Ongoing); New Amsterdam Pharma: Consultant (Ongoing); nference: Shareholder (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); NovoNordisk: Consultant (Ongoing); PERT Consortium: Consultant (Ongoing); Pfizer: Consultant (Ongoing); PhaseBio: Consultant (Ongoing); plx pharma: Consultant (Ongoing); Revance Therapeutics: Consultant (Ongoing); Samsung: Consultant (Ongoing); SCAD Alliance: Consultant (Ongoing); SCAI: Consultant (Ongoing); SFJ: Consultant (Ongoing); Somahlution/Marizyme: Consultant (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing); Vecutra: Consultant (Ongoing); WebMD: Consultant (Ongoing); Woman As One: Consultant (Ongoing)

David F. Kong, MD, AM, DMT: No financial relationships to disclose

Presentations:

8:00 AM – 8:10 AM ET

Artificial Intelligence-Derived Automated Intravascular Ultrasound-Based Calcium Score to Predict Stent (Under-)Expansion in Severely Calcified Lesions
Speaker: Saurav Chatterjee, MD – Long Island Jewish Hospital/Northwell Health
8:10 AM – 8:15 AM ET

Panel Discussion
8:15 AM – 8:25 AM ET

Artificial Intelligence System for Identifying and Notifying Hazardous Situations in the Catheterization Laboratory
Speaker: Yair Feld, MD, PhD – Tzafon Medical Center (Poriya)
8:25 AM – 8:30 AM ET

Panel Discussion
8:30 AM – 8:40 AM ET

ECGio – An AI Algorithm to Predict the Presence and Severity of Flow-Limiting CAD Using a Standard 12-Lead ECG
Speaker: Michael Leasure – HEARTio
8:40 AM – 8:45 AM ET

Panel Discussion
8:45 AM – 8:55 AM ET

4TAVR - A Fully Automated Cloud-Based AI-Driven Pre-Procedural TAVR Planning Software
Speaker: Moritz C. Wyler von Ballmoos, MD, PhD, MPH – Texas Health Resources & TCU
8:55 AM – 9:00 AM ET

Panel Discussion
9:00 AM ET

Adjourn